EagleTribune.com, North Andover, MA

November 5, 2013

N.H. gets $3.8M in drug settlement


The Eagle-Tribune

---- — CONCORD (AP) — New Hampshire is getting $3.8 million as part of a multi-state settlement with pharmaceutical manufacturer Johnson & Johnson to revolve criminal and civil allegations that the company promoted powerful psychiatric drugs for unapproved uses in children, seniors and disabled patients.

This settlement resolves allegations that the manufacturer unlawfully promoted and marketed Risperdal and Invega for uses that were not approved by the Food and Drug Administration and for uses that were not medically indicated.

The $2.2 billion agreement is the third-largest settlement with a drugmaker in U.S. history, and the latest in a string of actions against drug companies allegedly putting profits ahead of patients.